Mirjam de With
5PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Nov 10, 2022
Response to "Plasma Uracil as a DPD Phenotyping Test: Pre-analytical Handling Matters".Mirjam de With, Jonathan Knikman, Jan H M Schellens
|Jul 21, 2022
DPYD*7 as a Predictor of Severe Fluoropyrimidine-Related Adverse Events.Mirjam de With, Gemma Brufau, Laila A van den Berg
|Apr 03, 2021
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy.Mirjam de With, Daan P Hurkmans, Esther Oomen-de Hoop
|Mar 06, 2021
Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy.Tessa A M Mulder, Mirjam de With, Marzia Del Re
|Dec 13, 2019
Effects of pharmacogenetic variants on vemurafenib-related toxicities in patients with melanoma.Andrew Kl Goey, Mirjam de With, Bram C Agema
Pageof 1
Frequent Collaborators
4 joint publications
Ron H J Mathijssen
2 joint publications
Sander Bins
1 joint publications
Andrew Kl Goey
1 joint publications
Tessa A M Mulder
1 joint publications
Marzia Del Re
1 joint publications
Romano Danesi
1 joint publications
Esther Oomen-de Hoop
1 joint publications
Reno Debets
1 joint publications
Astrid A M van der Veldt
1 joint publications
Ron H N van Schaik
